Madrigal Pharmaceuticals, Inc. MDGL Business Segments — Other segment (expense) income
Discontinued — last reported Q3 '25
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestIncomeExpenseNonoperatingNet.
The official record: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed November 4, 2025, on SEC EDGAR. View the filing →
Ask your AI about Madrigal Pharmaceuticals, Inc.'s business segments — other segment (expense) income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Madrigal Pharmaceuticals, Inc.'s business segments — other segment (expense) income?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported business segments — other segment (expense) income of -$215K in Q3 2025.
- What does business segments — other segment (expense) income mean?
- Incidental income or expenses related to the segment that are not part of core operating costs.
- How do you interpret business segments — other segment (expense) income?
- Fluctuations are often non-recurring; consistent negative values may indicate ongoing operational friction, while positive values may reflect one-time gains or recoveries.
- How does business segments — other segment (expense) income compare across companies?
- Similar to 'Other Operating Income/Expense' found in segment reporting notes for diversified life sciences companies.